We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
SYK Stock Gains on Launch of Hands-Free Device: Sync Badge
Read MoreHide Full Article
Stryker (SYK - Free Report) recently announced the launch of its hands-free, wearable communication device, Sync Badge, to support care team members with fast and reliable collaborations.
Sync Badge should help care providers offset ongoing nurse shortage by simplifying workflows and connecting to essential people and information. The device includes hands-free communication with wake word, dedicated panic button, Do Not Disturb mode and urgent call breakthrough. It can integrate with different connected devices and software platforms.
Likely Trend of SYK Stock Following the News
Following the announcement, shares of the company rose 2.3% to $394.88 at yesterday’s closing. In the year-to-date period, SYK’s shares have gained 11.7% compared with the medical products industry’s 6.9% growth. The S&P 500 has increased 8.4% in the same time frame.
Image Source: Zacks Investment Research
Given the ongoing nursing shortage, SYK’s Sync Badge is likely to boost the company’s business and generate additional revenues, which can further raise the stock’s price.
SYK currently has a market capitalization of $147.4 billion. In the last reported quarter, SYK delivered an earnings surprise of 3.49%.
Sync Badge: Revolutionizing Healthcare Communication
The company’s Sync Badge is a groundbreaking hands-free communication device designed to enhance collaboration in fast-paced healthcare environments. This wearable device allows care team members to use voice commands for seamless communication, addressing the increasing challenges posed by nursing shortages and demanding patient care settings.
By saying “Okay Vocera,” users can connect with colleagues based on name, role, or group, ensuring swift coordination. The Vocera communication platform complements the Sync Badge by providing a comprehensive clinical workflow solution, reducing the cognitive burden on healthcare workers and improving decision-making.
The Sync Badge also features a dedicated panic button for emergencies, allowing security personnel to locate and communicate with staff in distress. Additionally, the device integrates with various connected healthcare systems, providing real-time notifications for alarms, lab results and medical devices. By reducing workflow inefficiencies and enhancing safety, the Sync Badge significantly improves the responsiveness and effectiveness of patient care teams.
Stryker’s Hands-On Patient Care Solutions
Stryker has established itself as a leader in hands-on patient care through a diverse range of medical technologies, and Sync Badge will boost its portfolio further. The company’s acute and emergency care solutions provide advanced tools for hospitals and emergency responders, ensuring timely and effective treatment. Stryker’s neurotechnology and spine innovations enable precise and minimally invasive procedures, improving patient outcomes in complex surgeries. Its surgical technologies, including orthopedic instruments and craniomaxillofacial solutions, enhance the capabilities of medical professionals in trauma and reconstructive surgeries.
Stryker’s integration of digital, robotics, and enabling technologies further strengthens its patient care services. Its Mako SmartRobotics system, for instance, enhances precision in orthopedic surgeries, allowing for better implant placement and faster recovery times.
SYK’s Recent Developments
In January, Stryker reported robust fourth-quarter results, driven by strong performance in the U.S. market, notably in Instruments, Medical, Endoscopy, Trauma and Extremities and Mako. Strong International sales also buoyed optimism. SYK expects the momentum in the international market to continue in 2025.
The company signed an agreement in the same month to acquire Inari Medical for approximately $4.9 billion. The acquisition is likely to expand its portfolio and provide life-saving solutions to patients with peripheral vascular diseases. SYK completed the acquisition last month by tendering an offer for all outstanding shares of common stock of Inari Medical.
SYK also announced a definitive agreement in January to sell its U.S. spinal implants business to Viscogliosi Brothers, LLC, a family-owned investment firm specializing in the neuro-musculoskeletal space, to create a newly formed company called VB Spine, LLC. This reflects a strategic move to streamline Stryker’s portfolio by divesting its U.S. spinal implants business, enabling it to focus on higher-growth areas.
Some better-ranked stocks in the broader medical space are Masimo (MASI - Free Report) , Boston Scientific (BSX - Free Report) , and Cardinal Health (CAH - Free Report) . At present, Masimo carries a Zacks Rank #1 (Strong Buy), whereas Boston Scientific and Cardinal Health carry a Zacks Rank #2 (Buy) each.
Estimates for MASI’s 2024 earnings per share (EPS) have increased 1.2% to $4.10 in the past 30 days. MASI’s earnings beat estimates in each of the trailing four quarters, the average surprise being 17.1%. In the last reported quarter, it posted an earnings surprise of 16.6%.
Boston Scientific
Estimates for Boston Scientific’s 2025 EPS have jumped 2.9% to $2.85 in the past 30 days. Shares of the company have surged 56.7% in the past year compared with the industry’s growth of 12.5%. BSX’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 8.25%. In the last reported quarter, it delivered an earnings surprise of 7.69%.
Cardinal Health
Estimates for Cardinal Health’s fiscal 2025 EPS have increased 1.5% to $7.94 in the past 30 days. Shares of the company have jumped 15.2% in the past year against the industry’s 4.1% decline. PAHC’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 9.6%. In the last reported quarter, it delivered an earnings surprise of 10.3%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
SYK Stock Gains on Launch of Hands-Free Device: Sync Badge
Stryker (SYK - Free Report) recently announced the launch of its hands-free, wearable communication device, Sync Badge, to support care team members with fast and reliable collaborations.
Sync Badge should help care providers offset ongoing nurse shortage by simplifying workflows and connecting to essential people and information. The device includes hands-free communication with wake word, dedicated panic button, Do Not Disturb mode and urgent call breakthrough. It can integrate with different connected devices and software platforms.
Likely Trend of SYK Stock Following the News
Following the announcement, shares of the company rose 2.3% to $394.88 at yesterday’s closing. In the year-to-date period, SYK’s shares have gained 11.7% compared with the medical products industry’s 6.9% growth. The S&P 500 has increased 8.4% in the same time frame.
Image Source: Zacks Investment Research
Given the ongoing nursing shortage, SYK’s Sync Badge is likely to boost the company’s business and generate additional revenues, which can further raise the stock’s price.
SYK currently has a market capitalization of $147.4 billion. In the last reported quarter, SYK delivered an earnings surprise of 3.49%.
Sync Badge: Revolutionizing Healthcare Communication
The company’s Sync Badge is a groundbreaking hands-free communication device designed to enhance collaboration in fast-paced healthcare environments. This wearable device allows care team members to use voice commands for seamless communication, addressing the increasing challenges posed by nursing shortages and demanding patient care settings.
By saying “Okay Vocera,” users can connect with colleagues based on name, role, or group, ensuring swift coordination. The Vocera communication platform complements the Sync Badge by providing a comprehensive clinical workflow solution, reducing the cognitive burden on healthcare workers and improving decision-making.
The Sync Badge also features a dedicated panic button for emergencies, allowing security personnel to locate and communicate with staff in distress. Additionally, the device integrates with various connected healthcare systems, providing real-time notifications for alarms, lab results and medical devices. By reducing workflow inefficiencies and enhancing safety, the Sync Badge significantly improves the responsiveness and effectiveness of patient care teams.
Stryker’s Hands-On Patient Care Solutions
Stryker has established itself as a leader in hands-on patient care through a diverse range of medical technologies, and Sync Badge will boost its portfolio further. The company’s acute and emergency care solutions provide advanced tools for hospitals and emergency responders, ensuring timely and effective treatment. Stryker’s neurotechnology and spine innovations enable precise and minimally invasive procedures, improving patient outcomes in complex surgeries. Its surgical technologies, including orthopedic instruments and craniomaxillofacial solutions, enhance the capabilities of medical professionals in trauma and reconstructive surgeries.
Stryker’s integration of digital, robotics, and enabling technologies further strengthens its patient care services. Its Mako SmartRobotics system, for instance, enhances precision in orthopedic surgeries, allowing for better implant placement and faster recovery times.
SYK’s Recent Developments
In January, Stryker reported robust fourth-quarter results, driven by strong performance in the U.S. market, notably in Instruments, Medical, Endoscopy, Trauma and Extremities and Mako. Strong International sales also buoyed optimism. SYK expects the momentum in the international market to continue in 2025.
The company signed an agreement in the same month to acquire Inari Medical for approximately $4.9 billion. The acquisition is likely to expand its portfolio and provide life-saving solutions to patients with peripheral vascular diseases. SYK completed the acquisition last month by tendering an offer for all outstanding shares of common stock of Inari Medical.
SYK also announced a definitive agreement in January to sell its U.S. spinal implants business to Viscogliosi Brothers, LLC, a family-owned investment firm specializing in the neuro-musculoskeletal space, to create a newly formed company called VB Spine, LLC. This reflects a strategic move to streamline Stryker’s portfolio by divesting its U.S. spinal implants business, enabling it to focus on higher-growth areas.
Stryker Corporation Stock Price
Stryker Corporation price | Stryker Corporation Quote
SYK’s Zacks Rank and Other Key Stock Picks
Stryker currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader medical space are Masimo (MASI - Free Report) , Boston Scientific (BSX - Free Report) , and Cardinal Health (CAH - Free Report) . At present, Masimo carries a Zacks Rank #1 (Strong Buy), whereas Boston Scientific and Cardinal Health carry a Zacks Rank #2 (Buy) each.
Masimo
Masimo’s shares have rallied 30.1% in the past year. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Estimates for MASI’s 2024 earnings per share (EPS) have increased 1.2% to $4.10 in the past 30 days. MASI’s earnings beat estimates in each of the trailing four quarters, the average surprise being 17.1%. In the last reported quarter, it posted an earnings surprise of 16.6%.
Boston Scientific
Estimates for Boston Scientific’s 2025 EPS have jumped 2.9% to $2.85 in the past 30 days. Shares of the company have surged 56.7% in the past year compared with the industry’s growth of 12.5%. BSX’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 8.25%. In the last reported quarter, it delivered an earnings surprise of 7.69%.
Cardinal Health
Estimates for Cardinal Health’s fiscal 2025 EPS have increased 1.5% to $7.94 in the past 30 days. Shares of the company have jumped 15.2% in the past year against the industry’s 4.1% decline. PAHC’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 9.6%. In the last reported quarter, it delivered an earnings surprise of 10.3%.